IGC Pharma Inc (IGC)
0.427
-0.01
(-2.73%)
USD |
NYAM |
Apr 25, 11:04
IGC Pharma Gross Profit (Quarterly): 0.133M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.133M |
September 30, 2023 | 0.174M |
June 30, 2023 | 0.255M |
March 31, 2023 | 0.063M |
December 31, 2022 | 0.102M |
September 30, 2022 | 0.135M |
June 30, 2022 | 0.142M |
March 31, 2022 | 0.068M |
December 31, 2021 | 0.062M |
September 30, 2021 | 0.038M |
June 30, 2021 | 0.026M |
March 31, 2021 | 0.027M |
December 31, 2020 | 0.014M |
September 30, 2020 | 0.026M |
June 30, 2020 | 0.046M |
March 31, 2020 | 0.016M |
December 31, 2019 | 0.03M |
September 30, 2019 | 0.028M |
June 30, 2019 | 0.041M |
March 31, 2019 | 0.027M |
December 31, 2018 | 0.045M |
September 30, 2018 | 0.018M |
June 30, 2018 | 0.042M |
March 31, 2018 | -0.076M |
December 31, 2017 | 0.039M |
Date | Value |
---|---|
September 30, 2017 | 0.072M |
June 30, 2017 | 0.046M |
March 31, 2017 | 0.0073M |
December 31, 2016 | 0.128M |
September 30, 2016 | 0.0716M |
June 30, 2016 | 0.0866M |
March 31, 2016 | 0.2673M |
December 31, 2015 | 0.206M |
September 30, 2015 | 0.166M |
June 30, 2015 | 0.204M |
March 31, 2015 | 0.1227M |
December 31, 2014 | 0.1991M |
September 30, 2014 | 0.1813M |
June 30, 2014 | 0.0766M |
March 31, 2014 | -0.0059M |
December 31, 2013 | 0.0097M |
September 30, 2013 | 0.1901M |
June 30, 2013 | 0.1877M |
March 31, 2013 | 0.2158M |
December 31, 2012 | 0.744M |
September 30, 2012 | 0.2431M |
June 30, 2012 | 0.3302M |
March 31, 2012 | -0.6749M |
December 31, 2011 | -0.038M |
September 30, 2011 | 0.0086M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.014M
Minimum
Dec 2020
0.255M
Maximum
Jun 2023
0.0751M
Average
0.046M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.053M |
NovaBay Pharmaceuticals Inc | 1.815M |
Protalix BioTherapeutics Inc | 1.63M |
Palatin Technologies Inc | 1.936M |